Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological DiseasesKyoka Hoshi(Fukushima Medical University), Yasuhiro Hashimoto(Fukushima Medical University)International Journal of Molecular SciencesMarch 23, 202310.3390/ijms24076084Cited by 1SaveCiteExport RISWatch citationsRelated PapersEvaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus|PLoS ONE|2017|44Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease|Metabolites|2021|34High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer’s Disease|Metabolites|2022|5